Your new post is loading...
Efficacy trial reaches endpoint and companies plan to soon submit data for emergency use authorizations in the U.S. and elsewhere
|
Scooped by Benoit Lamy |
Scoop.it!
No comment yet.
Sign up to comment
The two firms will request within days an emergency use authorization of their vaccine to the FDA.